MYL

3 Pharma Stocks to Buy Into Earnings

We'll learn a lot about healthcare names over the course of this earnings season -- I'm expecting big things from these three drugmakers. More

3 Generic Drug Stocks to Buy Right Away

Generic drugs are forecast to be the single fastest-growing industry for the next several years. Here are three stocks to profit from this trend. More

The 10 Best Stocks of 2013 Through Q1

A quarter into our contest, only two stocks are beating the market's double-digit gains ... and the bottom three entries are downright ugly. Take a look. More

Ranking the 10 Best Stocks for 2013

Two months into 2013, half of these expert stock picks are beating the broader market's gains, and all but two are in the black. More

Bullish Opportunity in Mylan Earnings

Short interest in pharma stock Mylan (MYL) increased 13% ahead of earnings, despite the company's strong fundamentals. Buy MYL to be on the right side of a short squeeze. More

How to Ride Mylan’s Steady Rise

A covered call strategy is perfect for this tortoise of a stock. The generic-drug maker is creeping to new highs without much overhead resistance. More

4 Pharmaceutical Stocks to Buy Now

This week, four Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More